Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Marberger

Showing results (211-220 of 250) with videos related to

Pageof 25
Sort By:
Urological Research|April 16, 1998
N-acetylneuraminic acids (nana): a potential key in renal calculogenesisJ Hofbauer, S Fang-Kircher, G Steiner, et al.
BJU International|October 6, 1999
The importance of measuring the prostatic transition zone: an anatomical and radiological studyA R Zlotta, B Djavan, M Damoun, et al.
Urology|March 30, 1999
Paclitaxel and carboplatin in patients with metastatic transitional cell cancer of the urinary tractA Pycha, M Grbovic, B Posch, et al.
The Journal of Urology|August 8, 2001
Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection studyB Djavan, M Waldert, A Zlotta, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 17, 2001
Local intratumoral tumor necrosis factor-alpha and systemic IFN-alpha 2b in patients with locally advanced prostate cancerG Kramer, G E Steiner, P Sokol, et al.
The Prostate|October 6, 1998
Expression of the aryl hydrocarbon receptor (AhR) and the aryl hydrocarbon receptor nuclear translocator (ARNT) in fetal, benign hyperplastic, and malignant prostateM Kashani, G Steiner, A Haitel, et al.
Urology|June 15, 1999
Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis?B Djavan, S Shariat, K Ghawidel, et al.
International Journal of Cancer|July 18, 2000
A polymorphism in the CYP17 gene is associated with prostate cancer riskA Gsur, G Bernhofer, S Hinteregger, et al.
BJU International|November 18, 2003
The clinical implications of the prostate cancer prevention trialM Marberger, J Adolfsson, A Borkowski, et al.
Urology|February 5, 1999
Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trialB Djavan, S Shariat, M Fakhari, et al.
Pageof 25

Showing results (211-220 of 250) with videos related to

Sort By:
Pageof 25
Urological Research|April 16, 1998
N-acetylneuraminic acids (nana): a potential key in renal calculogenesisJ Hofbauer, S Fang-Kircher, G Steiner, et al.
BJU International|October 6, 1999
The importance of measuring the prostatic transition zone: an anatomical and radiological studyA R Zlotta, B Djavan, M Damoun, et al.
Urology|March 30, 1999
Paclitaxel and carboplatin in patients with metastatic transitional cell cancer of the urinary tractA Pycha, M Grbovic, B Posch, et al.
The Journal of Urology|August 8, 2001
Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection studyB Djavan, M Waldert, A Zlotta, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 17, 2001
Local intratumoral tumor necrosis factor-alpha and systemic IFN-alpha 2b in patients with locally advanced prostate cancerG Kramer, G E Steiner, P Sokol, et al.
The Prostate|October 6, 1998
Expression of the aryl hydrocarbon receptor (AhR) and the aryl hydrocarbon receptor nuclear translocator (ARNT) in fetal, benign hyperplastic, and malignant prostateM Kashani, G Steiner, A Haitel, et al.
Urology|June 15, 1999
Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis?B Djavan, S Shariat, K Ghawidel, et al.
International Journal of Cancer|July 18, 2000
A polymorphism in the CYP17 gene is associated with prostate cancer riskA Gsur, G Bernhofer, S Hinteregger, et al.
BJU International|November 18, 2003
The clinical implications of the prostate cancer prevention trialM Marberger, J Adolfsson, A Borkowski, et al.
Urology|February 5, 1999
Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trialB Djavan, S Shariat, M Fakhari, et al.
Pageof 25